Evidence map›Paper›PMID 37974029›Full record

ReviewNature protocols2024

A nanobody-based strategy for rapid and scalable purification of human protein complexes.

Taylor Anthony Stevens, Giovani Pinton Tomaleri, Masami Hazu, Sophia Wei, Vy N Nguyen, Charlene DeKalb, Rebecca M Voorhees, Tino Pleiner

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. No evidence for direct physical interaction of 5-HTbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Structural evolution of the MTCH family of mitochondrial insertases.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Structural and functional analysis of theProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Taylor Anthony StevensDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID 0000-0002-6232-5316
Giovani Pinton TomaleriDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Masami HazuDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID 0000-0002-6527-9597
Sophia WeiDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Vy N NguyenDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID 0000-0002-7563-7386
Charlene DeKalbDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID 0000-0002-8277-1137
Rebecca M VoorheesDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. voorhees@caltech.edu.
Tino PleinerDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. pleiner@stanford.edu.ORCID 0000-0002-5104-0315
California Institute of Technology · US

Funding

Protein complex assembly in the ER membraneDP2GM137412 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI VOORHEES, REBECCA · 2019 to 2019
$2.5M
Deutsche Forschungsgemeinschaft (German Research Foundation) PL 899/1-1NIGMS NIH HHS DP2 GM137412U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) DP2GM137412
6 · The paper itself

Abstract

The isolation of proteins in high yield and purity is a major bottleneck for the analysis of their three-dimensional structure, function and interactome. Here, we present a streamlined workflow for the rapid production of proteins or protein complexes using lentiviral transduction of human suspension cells, combined with highly specific nanobody-mediated purification and proteolytic elution. Application of the method requires prior generation of a plasmid coding for a protein of interest (POI) fused to an N- or C-terminal GFP or ALFA peptide tag using a lentiviral plasmid toolkit we have designed. The plasmid is then used to generate human suspension cell lines stably expressing the tagged fusion protein by lentiviral transduction. By leveraging the picomolar affinity of the GFP and ALFA nanobodies for their respective tags, the POI can be specifically captured from the resulting cell lysate even when expressed at low levels and under a variety of conditions, including detergents and mild denaturants. Finally, rapid and specific elution of the POI (in its tagged or untagged form) under native conditions is achieved within minutes at 4 °C, using the engineered SUMO protease SENP

Indexed as

PeptidesProteinsChromatography, AffinityHumansProteolysisRecombinant Fusion ProteinsPeptidesProteinsRecombinant Fusion Proteins

Identifiers

PMID37974029
OpenAlexW4388729175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.